Memmert India Laboratory Equipment Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
- Paid Up Capital ₹ 2.10 M
- Company Age 11 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -18.86%
- Profit Growth 13.36%
- Ebitda 11.12%
- Net Worth -60.37%
- Total Assets -49.87%
About Memmert India Laboratory Equipment
Memmert India Laboratory Equipment Private Limited (MILEPL) is a Private Limited Foreign Company Incorporated In India incorporated in India on 30 December 2013 and has a history of 11 years and one month. Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 2.10 M, as per Ministry of Corporate Affairs (MCA) records.
Shailesh Bhat, Chrisitane Karpa, Philipp Schwarm, and One other member serve as directors at the Company.
Company Details
- Location
Pune, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74900PN2013FTC149936
- Company No.
149936
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
30 Dec 2013
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Memmert India Laboratory Equipment?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shailesh Bhat  | Whole-Time Director | 30-Dec-2013 | Current |
Chrisitane Karpa  | Director | 15-Feb-2020 | Current |
| Philipp Schwarm | Director | 15-Feb-2020 | Current |
| Frank Brunner | Additional Director | 19-Mar-2024 | Current |
Financial Performance of Memmert India Laboratory Equipment.
Memmert India Laboratory Equipment Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 18.86% decrease. The company also saw a substantial improvement in profitability, with a 13.36% increase in profit. The company's net worth observed a substantial decline by a decrease of 60.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Memmert India Laboratory Equipment?
In 2023, Memmert India Laboratory Equipment had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Memmert India Laboratory Equipment?
Unlock and access historical data on people associated with Memmert India Laboratory Equipment, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Memmert India Laboratory Equipment, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Memmert India Laboratory Equipment's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
